Kumar, S. et al. 2025. Commentary on “Pembrolizumab in gestational trophoblastic neoplasia: systematic review and meta-analysis with sub-group analysis of potential prognostic factors. Clinics. 80, (Jan. 2025), 100651. DOI:https://doi.org/10.1590/.